| Dr Michael Florie, DPM | |
|
720 Washington Ave Se, Minneapolis, MN 55414-2904 | |
| (520) 792-1450 | |
| Not Available |
| Full Name | Dr Michael Florie |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 5 Years |
| Location | 720 Washington Ave Se, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700441102 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 1110 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Preferred Podiatry Group Pc | 3971412677 | 114 |
| Preferred Podiatry Group Pc | 3971412677 | 114 |
| Preferred Podiatry Group Pc | 3971412677 | 114 |
News Archive
Adolescents, especially those who are not very physically active, eat too much sweet and fatty foods and not enough fruits and vegetables. This is the conclusion of a study from the Sahlgrenska Academy, at the University of Gothenburg, Sweden, on dietary choices, exercise habits and prevalence of obesity among young people.
HealthGrades, the leading provider of information to help consumers make an informed decision about a physician or hospital and CPM, the leading provider of customer relationship management solutions for hospitals today announced a definitive agreement to merge the two companies.
Trius Therapeutics, Inc. announced that the first patient has been dosed in its Phase 3 clinical study of the oral dosage form of torezolid phosphate for the treatment of acute bacterial skin and skin structure infections (ABSSSI). The double-blind, active control, pivotal study is designed to compare the efficacy and safety of once-daily oral administration of 200 milligrams of torezolid phosphate for six days of treatment with the efficacy and safety of twice-daily oral administration of 600 milligrams of linezolid (Zyvox®) for 10 days of treatment.
The diagnosis of diseases like cancer almost always needs a biopsy - a procedure where a clinician removes a piece of suspect tissue from the body to examine it, typically under a microscope.
A new treatment option for Canadians with schizophrenia, ABILIFY(TM) (aripiprazole), is now available in Canada. For those living with this lifelong disease who may be struggling with a treatment that doesn't work for them or with side effects that are difficult to tolerate, ABILIFY offers efficacy and good safety and tolerability with limited impact on weight, blood sugar and lipids - significant clinical benefits that may help patients stay on treatment longer.
› Verified 2 days ago
| Provider Name | Preferred Podiatry Group Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1720037138 PECOS PAC ID: 3971412677 Enrollment ID: O20161222000196 |
News Archive
Adolescents, especially those who are not very physically active, eat too much sweet and fatty foods and not enough fruits and vegetables. This is the conclusion of a study from the Sahlgrenska Academy, at the University of Gothenburg, Sweden, on dietary choices, exercise habits and prevalence of obesity among young people.
HealthGrades, the leading provider of information to help consumers make an informed decision about a physician or hospital and CPM, the leading provider of customer relationship management solutions for hospitals today announced a definitive agreement to merge the two companies.
Trius Therapeutics, Inc. announced that the first patient has been dosed in its Phase 3 clinical study of the oral dosage form of torezolid phosphate for the treatment of acute bacterial skin and skin structure infections (ABSSSI). The double-blind, active control, pivotal study is designed to compare the efficacy and safety of once-daily oral administration of 200 milligrams of torezolid phosphate for six days of treatment with the efficacy and safety of twice-daily oral administration of 600 milligrams of linezolid (Zyvox®) for 10 days of treatment.
The diagnosis of diseases like cancer almost always needs a biopsy - a procedure where a clinician removes a piece of suspect tissue from the body to examine it, typically under a microscope.
A new treatment option for Canadians with schizophrenia, ABILIFY(TM) (aripiprazole), is now available in Canada. For those living with this lifelong disease who may be struggling with a treatment that doesn't work for them or with side effects that are difficult to tolerate, ABILIFY offers efficacy and good safety and tolerability with limited impact on weight, blood sugar and lipids - significant clinical benefits that may help patients stay on treatment longer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Florie, DPM 720 Washington Ave Se, Minneapolis, MN 55414-2924 Ph: (860) 917-6037 | Dr Michael Florie, DPM 720 Washington Ave Se, Minneapolis, MN 55414-2904 Ph: (520) 792-1450 |
News Archive
Adolescents, especially those who are not very physically active, eat too much sweet and fatty foods and not enough fruits and vegetables. This is the conclusion of a study from the Sahlgrenska Academy, at the University of Gothenburg, Sweden, on dietary choices, exercise habits and prevalence of obesity among young people.
HealthGrades, the leading provider of information to help consumers make an informed decision about a physician or hospital and CPM, the leading provider of customer relationship management solutions for hospitals today announced a definitive agreement to merge the two companies.
Trius Therapeutics, Inc. announced that the first patient has been dosed in its Phase 3 clinical study of the oral dosage form of torezolid phosphate for the treatment of acute bacterial skin and skin structure infections (ABSSSI). The double-blind, active control, pivotal study is designed to compare the efficacy and safety of once-daily oral administration of 200 milligrams of torezolid phosphate for six days of treatment with the efficacy and safety of twice-daily oral administration of 600 milligrams of linezolid (Zyvox®) for 10 days of treatment.
The diagnosis of diseases like cancer almost always needs a biopsy - a procedure where a clinician removes a piece of suspect tissue from the body to examine it, typically under a microscope.
A new treatment option for Canadians with schizophrenia, ABILIFY(TM) (aripiprazole), is now available in Canada. For those living with this lifelong disease who may be struggling with a treatment that doesn't work for them or with side effects that are difficult to tolerate, ABILIFY offers efficacy and good safety and tolerability with limited impact on weight, blood sugar and lipids - significant clinical benefits that may help patients stay on treatment longer.
› Verified 2 days ago
Todd Arnold Shea, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 825 Nicollet Mall Ste 300, Minneapolis, MN 55402 Phone: 612-333-8883 | |
Downtown Skyway Foot Specialists Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 825 Nicollet Mall, Suite 517 Medical Arts Bldg, Minneapolis, MN 55402 Phone: 612-332-7720 Fax: 612-333-8981 | |
Advanced Foot & Ankle Care Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 825 Nicollet Mall, Suite 601, Minneapolis, MN 55402 Phone: 763-550-1013 Fax: 763-550-0615 | |
Dennis Jay Oeltjenbruns, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 800 E 28th St, Minneapolis, MN 55407 Phone: 952-946-9777 | |
Dr. Tanler Juris Volkmann, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 800 E 28th St, Minneapolis, MN 55407 Phone: 612-863-3110 Fax: 612-863-3158 | |
Dr. Lisa Lee Cummings, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 7801 E Bush Lake Rd Ste 400, Minneapolis, MN 55439 Phone: 952-283-3162 Fax: 866-991-7241 | |
Dr. Gregory Todd Rifleman, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1 Veterans Drive, Minneapolis, MN 55417 Phone: 612-467-4685 |